Browse By: Country ι Category ι Publisher ι Tag

Vaccine Partnering Terms and Agreements

Pages » 1021
Published By » Current Partnering
Price » $2995
In stock
View Report Details
Description

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines   The report provides a detailed understanding and analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the lic... Click here for more details


Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis
Published Date: Sep 2013
Price: $2995
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jul 2014
Price: $2995
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This rep
Published Date: Jul 2011
Price: $2995
Pharmacogenomic Partnering Terms and Agreements
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analy
Published Date: Apr 2011
Price: $2695
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering a
Published Date: Sep 2013
Price: $2795
Companion Diagnostics Partnering Terms and Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe companion diagnostics partnering deals and agreements entered intby the worlds leading healthcare companies.   The report provides a detailed underst
Published Date: Oct 2013
Price: $1795
Partnering Terms and Agreements in Diagnostics, 2nd edition
The Partnering Terms and Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and
Published Date: Nov 2010
Price: $2695
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding and anal
Published Date: Jun 2010
Price: $2695
Option & Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provide
Published Date: Sep 2013
Price: $2795
Pre-clinical Stage Partnering Terms & Agreements in Pharma, Biotech & Diagnostics
The Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement. The report provides a detailed under
Published Date: Jun 2010
Price: $2695

 


 

Related News

China’s Huawei to Setup 4G Network in Cambodia
EMAXX, the Cambodian telecommunications company has signed a deal with the Chinese Huawei on Wednesday to build and develop a 4G network in Cambodia. The contract was signed by Ai Minn, the CEO of EMAXX, and the DGM of Huawei Technologies Weng Kefeng. The signing was performed in the presence of the Chinese Embassy’s Cambodian political councilor Li Zhigong and Kan Channmeta, Secretary of State at the Cambodian Ministry of Posts and Telecom. The contract states that Huawei will build
Date: Sep 18

Cost Watchdog of Britain’s Healthcare Sector Approves GSK’s Melanoma Drug under Price-Cut Conditions
Cost control agency of Britain’s healthcare sector, The National Institute for Health and Care Excellence (NICE), has recommended a drug for melanoma marketed by GlaxoSmithKline after the drug maker offered to supply it at a discounted rate to the National Health Service.  The drug, titled Tafinlar, is currently marketed by GSK but it will soon be transferred to Novartis under a trade deal between the tow companies.  Tafinlar is an oral drug that works in a way similar to R
Date: Sep 18

GFT Publishes Big Data for Financial Services Industry
According to the electronic newsletter issued by the California Independent Petroleum Association on Monday, the refinery project poses major economic questions regarding bringing extra crude barrels into the California market. This will affect the local crude prices in the state.  The oil-by-rail project of Alon USA Energy Inc. on Rosedale Highway stirs several questions regarding the local crude prices in the oil industry of California.  Alon is a Dallas-based oil company that
Date: Sep 18

Weakening Rouble Makes GM Cut Production and Cut Jobs in Russia
Opel Group, the European subsidiary of general Motors has planned to cut production and shed nearly 500 jobs in Russia. The decision comes ahead of the weakening Russian rouble and the drop in local demand due to slow economic growth and Western sanctions. Opel stated that it would cut production from two shifts per day to one, at its St. Petersburg plant where it produces Chevrolet Cruze compact and Opel Astra. The company will also offer voluntary severance letters to nearly 500 of the p
Date: Sep 17

Only 44% Americans Think College Education “Very Important”: Poll
A recent annual poll has revealed some shocking statistics regarding Americans’ views on the need for a college education. The poll showed that only 44% of Americans believed that a college education was “very important”, a drastic drop from 75% just four years ago. The 46th annual PDK-Gallup poll also found that most parents of kids in public schools wish that teacher training programs be more selective and that new teachers work under a certified teacher for at least a yea
Date: Sep 17

Fashion Industry Embraces Technology at London Fashion Week
The London Fashion Week cast the spotlight this week not just on the clothes on the runway, but the technology that surrounded the event. In what could be termed as a new digital first for the fashion industry, Burberry teamed up with Twitter to launch the new click-to-buy button to people across the globe. The British luxury fashion house made its nail paint that will be showcased at the LFW available to Twitterati. The social media website is currently trying out the “buy now” feat
Date: Sep 16

Bitcoin Mining Firm Free from Cease Trade
A Saskatchewan based Dominion Bitcoin Mining Company is now free from cease trade and is operating once again.  The cease-trade order against Bitcoin was lifted in May by the Financial and Consumer Affairs Authority (FCAA) with no penalty being issued after it expired last week.  FCAA’s action toward originally issuing the order was because it believed the mining firm had been looking out for various investors in the Saskatchewan region without actually being registered to
Date: Sep 16

Hawaii Earns a “C” in the Blue Planet Foundation’s 2014 Energy Report Card
According to a report published by Blue Planet Foundation, Hawaii received an “average” grade for its clean energy progress. The Blue Planet Foundation’s 2014 Energy Report Card for Hawaii has shown a slight improvement since 2013 which was at “C-minus”. This year the report card has improved to “C”. The report is a 42-page document which gives a broad perspective of Hawaii’s energy transformation. It overlooks key aspects such as transportation
Date: Sep 16

Coke’s Surge to be Reintroduced in the Global Beverages Market
A flavored drink that was discontinued more than a decade ago by Coca Cola, has again been brought back in the beverages market. This citrus flavored drink called Surge is a Mountain Dew knockoff. This drink is only available at Amazon.com. This happens to be Coca Cola’s first ever e-commerce reintroduction. The reintroduction of Surge has been announced at the “Surge Movement” which is a Facebook Fan site.  The members of this fan site are excited about the return of t
Date: Sep 16

Cipla Rises by 10% in Two Days
In a relatively weaker market, Cipla has managed to rally stocks by 3% up to $10.34, a record high for the pharmaceutical company in the National Stock Exchange (NSE). The latest rally brings the stock for Cipla up by nearly 10% within a span of two days. The stocks rose from a previous $9.46 two days ago. The growth added some relief to a CNX Nifty market that was declining by 1%. The stocks started gaining ground after Cipla launched their anti-asthma inhalers in Germany and Sweden. The
Date: Sep 15

Upcoming Reports

DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
Vaccines have been in use since decades to provide immunological responses against diseases. A conventional vaccine is a biological preparation of weakened or attenuated, killed forms of a microbe or one of its cellular components, while a DNA vaccine is composed of genetically engineered DNA. Whe
Published By: Transparency Market Research
Price: $4795
HPV Therapeutic Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers
Published By: Transparency Market Research
Price: $4795
Preventable Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
The use of preventable vaccines is to avoid the occurrence of an infectious disease, which is preventable by the use of vaccines. The occurrence of death due to a vaccine-preventable disease is termed as vaccine-preventable death, the reason being failure to attain vaccines in time, lack of access t
Published By: Transparency Market Research
Price: $4795
Foot And Mouth Disease Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
Foot and mouth disease is considered as a highly contagious and severe disease observed in animals with considerable economic impact. Animals which are affected by foot and mouth disease include goat, sheep and cloven-hoofed ruminant. Deer, antelope, elephant and giraffe are susceptible to foot and
Published By: Transparency Market Research
Price: $4795